CNS Stimulants Flashcards
CNS Stimulants:
General properties
- Increase activity of CNS neurons
- Can either enhance excitation or suppress inhibition
- In sufficient doses, all stimulants can produce convulsions
- CNS stimulants have limited clinical usefulness
- Attention-deficit, hyperactivity disorder
- Narcolepsy
Caffeine:
- methylxanthine compound found in coffee
- found in cocoa and the kola nut
- theophylline & theobromine are found in tea leaves
- A cup or mug of coffee may have 80 to 200 mg of caffeine
Caffeine:
Mechanism of Action
-
Block adenosine receptors (equilibrium-competitive antagonist)
- Postsynaptic adenosine receptors produce IPSP’s
- Presynaptic adenosine receptors inhibit glutamate release
- Caffeine blocks both of these inhibitory effects (disinhibition) resulting in CNS stimulation
-
Inhibition of phosphodiesterase
- Results in increased cAMP concentrations
- property of these compounds that results in benefit for asthma
- Induces release of calcium from intracellular stores (endoplasmic reticulum)
Caffeine:
Pharmacological of Action
-
CNS stimulant:
- increased alertness and capacity or tasks requiring sustained attention
- Decreased fatigue and drowsiness
- Can cause nervousness, restlessness and tremors
- High doses can stimulate medullary respiratory, vasomotor and vagal centers
-
Peripheral actions:
- Stimulates myocardium - positive chronotropic & inotropic effects
-
Dilates coronary and general systemic blood vessels
- constricts cerebral blood vessels
- may underlie its usefulness in headache
- Diuretic effect
- Increases gastric secretion
- Modest bronchodilator activity
- not as much as theophylline
How is caffeine therapeutically useful?
- Used as an aid to stay awake
- Treatment of headache
Caffeine:
Toxicity and chronic use
-
Toxicity/overdose results in:
- excessive CNS stimulation, nervousness, insomnia, excitement
-
Chronic use
- Tolerance develops to stimulant effects of caffeine
- Physical dependence develops at a dose of two cups of coffee a day
- Withdrawal symptoms: fatigue/sleepiness; headaches; nausea; vomiting (rare)
Defintion: Sympathomimetic Stimulants
Compounds that act through the enhancement of catecholaminergic neuro-transmission
Cocaine:
Chemistry
-
Weak base, unprotonated form is unionized
- this form predominates at alkaline pH
-
Used in two major forms:
- cocaine hydrochloride: water soluble
- cocaine free base: lipid soluble, volatile
- free base is made by extracting cocaine base from an alkaline solution into ether
Cocaine:
Pharmacokinetics and Metabolism
-
Well absorbed through most mucous membranes
- including the lungs
-
Time to peak effect and duration of action are dependent on route of administration
- Shorter for IV & smoked cocaine
- Metabolized primarily by serum and liver esterases
- Can also be demethylated at the nitrogen
- Very short half-life (50 min)
- Testing for cocaine use: look for metabolites in urine
Cocaine:
Mechanisms of Action
-
Cocaine is a potent inhibitor of the reuptake of:
- norepinephrine, dopamine and serotonin
- Cocaine receptor on transporter for dopamine, competes for binding of the endogenous ligand ⇒ increased ligand in the synapse
-
Central reinforcing effects
- believed due to an action on dopamine synapses in the ventral striatum
-
Increases tyrosine and tryptophan hydroxylase
- loss of endproduct inhibition
- Local anesthetic; vasoconstrictor
Cocaine:
Pharmacological Effects
-
Peripheral sympathomimetic
- due to increased norepinephrine
- vasoconstriction; tachycardia
-
Increased alertness; vigilance
- increased NE in CNS
-
Produces euphoria, feelings of elation, well being and competency
- Due to ↑ DA in mesolimbic circuit
- High abuse potential - very reinforcing
Cocaine:
Toxicity and chronic use
- Tolerance and physical dependence occurs with heavy use
- Withdrawal syndrome – mild
- Neurotoxicological effects
- possible damage to dopamine systems
- Overdose ⇒ seizures and/or cardiovascular effects
-
Fetal effects are more significant than alcohol
- Low birth weights
- Learning and emotional problems
- Attachment disorder
Cocaine Abuse:
- **Psychological dependence: **
- High abuse liability
- Very reinforcing
- Results in drug craving and drug seeking
Why would you use cocaine clinically?
- Local anesthesia in upper respiratory tract
- also decreases blood flow
- useful for nose surgery
Amphetamine and amphetamine-like drugs:
Chemistry
- Most are α-methyl phenethylamine derivatives
- Weak base
Amphetamine and amphetamine-like drugs: Pharmacokinetics and Metabolism
- Well absorbed orally
-
Longer duration of action than cocaine
- 4-6 hours orally
-
Metabolism
- Deamination to benzoic acid (predominant route)
- Also excreted unchanged as amphetamine base excretion increased in acid urine
**Amphetamine and amphetamine-like drugs: **
Mechanisms of action
- Releases norepinephrine, dopamine and serotonin
- Blocks transmitter uptake into presynaptic terminals (like cocaine)
- Direct partial agonist of alpha-adrenergic receptors
- MAO inhibition (at high doses)
- More NE-‐like effects than cocaine
Amphetamine and amphetamine-like drugs: Pharmacological properties
-
Wakefulness, alertness, decreased fatigue
- more done, but more errors
- Enhances athletic and intellectual performance
- Elevation of mood; increased self-confidence
- Increase in motor and speech activities; speed
- Respiratory stimulation
- Decrease in appetite
- Peripheral sympathomimetic effects
Amphetamine and amphetamine-like drugs:
Specific agents (3)
all have similar effects; however, intensity of central
effects vary
- Amphetamine and dextroamphetamine
- Methamphetamine - better CNS bioavailability, more CNS effect, higher abuse liability
- Methylphenidate - not actually an amphetamine but structurally and mechanistically very similar
**Amphetamine and amphetamine-like drugs: **
Clinical uses
-
Narcolepsy: day time “sleep attacks”
- Amphetamine and dextroamphetamine
-
Attention-deficit hyperactivity disorder
- Amphetamine, dextroamphetamine and methylphenidate
- Excessive motor activity, racing thoughts, difficulty in sustained attention
- Academic underachievement
What are side effects associated with amphetamine and amphetamine-like drugs?
Side effects:
- Insomnia
- Abdominal pain
- Anorexia, weight loss
- Suppression of growth
- Fever
- Facial tics
Toxicity of amphetamines and methylphenidate:
-
Acute toxicity
- Sympathomimetic effects
- Restlessness, dizziness, tremor
- Psychosis (due to excessive dopamine)
- Neurotoxicity: abuse can lead to permanent intellectual problems
-
Abuse liability - very high
- Particularly for IV or smoked methamphetamine
- Abuse liability is similar to cocaine; clinical deterioration is worse because of neurotoxicity
Nicotine:
Mechanism of Action
Agonist of nicotinic cholinergic receptors
- Neuromuscular junction - not as affected
-
Autonomic ganglia
- Sympathetic ganglia activation ⇒ release of epinephrine
- Parasympathetic ganglia activation is predominant ⇒ GI effects (nausea; increased motility)
-
CNS receptors
- Found in many brain regions
- Results in membrane depolarization (excitation)
Nicotine:
Pharmacological actions
-
CNS stimulant
- Increased alertness
- Activates dopamine signaling in nucleus accumbens
- it is reinforcing
- Muscle relaxant
Nicotine is absorbed readily through _____ _________.
mucous membranes
How does nicotine affect the neuronal systems?
- Nicotine is reinforcing
- Activates neuronal systems designed to maintain behaviors that are important for survival
Describe tolerance to nicotine:
- Occurs over a very short time period
- hours; tachyphylaxis
- First cigarette of the day is the best
Nicotine withdrawal symptoms:
- Irritability, impatience, hostility
- Anxiety
- Depression
- Difficulty concentrating
- Increased appetite; weight gain
How nicotine addiction commonly treated?
Nicotine replacement therapy:
- Most widely used
- Replace nicotine (partially)
- Formulations:
- Nasal spray
- Gum
- Lozenge
- Sublingual tablet
- Vapor inhaler
- Patches (passive)
Bupropion (Zyban®):
-
Mechanism of action - unknown
- antidepressant
- seems to enhance noradrenergic and dopaminergic signaling
-
Adverse effects
- dry mouth, insomnia
-
Moderately effective
- reduces craving and nicotine withdrawal symptoms
Varenicline (Chantix™):
-
Partial agonist of CNS nicotinic receptors
- Activates nicotinic receptors alone enough to reduce craving and withdrawal
- Reduces the effects of the full agonist, nicotine
- Produces significant increase in abstinence compared to placebo
-
Adverse effects
- nausea; insomnia; headache; constipation
-
Recent FDA warning
- increases thoughts of suicide; depression